Metin Colpan

GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey

GenPat77 Pharmacogenetics AG researches and develops immune modulatory therapeutics for immune mediated diseases. The company was founded in 1998 and is headquartered in Berlin, Germany.

Ingenium Pharmaceuticals GmbH operates as a biopharmaceutical company specializing in the development of small molecule drugs. They develop inhibitors and ligands targeting key enzymes such as proteases and kinases. Their therapeutic compounds are used for the treatment of memory-related and chronic inflammatory disorders. Their focus areas cover human therapeutics, vivo pharmacology, and disease pathology. The company was founded in 1998 and is headquartered in Munich, Germany.

CC Verwaltungs GmbH provides management services. The private company is based in Dusseldorf, Germany. The German company was founded in 2001. The CEO is Metin Colpan.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Qalovis GmbH is a German company that specializes in manufacturing customised machines and systems for refining biogenic waste materials from biogas plants and livestock farming.

Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy.